Search

Your search keyword '"Peptides, Cyclic"' showing total 20,400 results

Search Constraints

Start Over You searched for: Descriptor "Peptides, Cyclic" Remove constraint Descriptor: "Peptides, Cyclic"
20,400 results on '"Peptides, Cyclic"'

Search Results

51. In Vitro Selection of Macrocyclic α/β

52. A Randomized Trial Evaluating Patient Experience and Preference Between Octreotide Long-Acting Release and Lanreotide for Treatment of Well-Differentiated Neuroendocrine Tumors

53. Optimized Coordination of Uranyl in Engineered Calmodulin Site 1 Provides a Subnanomolar Affinity for Uranyl and a Strong Uranyl versus Calcium Selectivity

54. Flaxseed Cyclic Peptide [1-9-NαC]-Linusorb B3 (CLA) Improves Oxidative Stability of Flaxseed Oil by Chelating Metal Ions and Intermediate Oxidative Products

55. Recombineering using RecET-like recombinases from Xenorhabdus and its application in mining of natural products

56. Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study

57. OFP011 Cyclic Peptide as a Multifunctional Agonist for Opioid/Neuropeptide FF Receptors with Improved Blood–Brain Barrier Penetration

58. A comprehensive review of microorganism‐derived cyclic peptides: Bioactive functions and food safety applications

60. Cortistatin-14 Exerts Neuroprotective Effect Against Microglial Activation, Blood-brain Barrier Disruption, and Cognitive Impairment in Sepsis-associated Encephalopathy

61. Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy

62. Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial

63. Applying Promiscuous RiPP Enzymes to Peptide Backbone

64. Optimizing Epitope Conformational Ensembles Using α-Synuclein Cyclic Peptide 'Glycindel' Scaffolds: A Customized Immunogen Method for Generating Oligomer-Selective Antibodies for Parkinson's Disease

65. A Computational Protocol for Vibrational Circular Dichroism Spectra of Cyclic Oligopeptides

66. The lipopeptides fengycin and iturin are involved in the anticandidal activity of endophytic Bacillus sp. as determined by experimental and in silico analysis

68. Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study

69. Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria

70. Optimization of Cyclic Peptide Property Using Chromatographic Capacity Factor on Permeability of Passive Cell Membrane and Human Induced Pluripotent Stem Cell-Derived Intestinal Membrane

71. The natural bicyclic hexapeptide RA-VII is a novel inhibitor of the eukaryotic translocase eEF2

72. Accessing Diverse Pyridine-Based Macrocyclic Peptides by a Two-Site Recognition Pathway

73. CXCR4-targeted theranostics in oncology

74. Cyclization and Docking Protocol for Cyclic Peptide–Protein Modeling Using HADDOCK2.4

75. Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren’s syndrome

76. PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK.

77. Previously Uncharacterized Variants, OCF-E-OCF-J, of the Antifungal Occidiofungin Produced by Burkholderia contaminans MS14.

78. Sol-gel Carbowax 20M-zwitterionic ionic liquid composite sorbent-based capsule phase microextraction device combined with HPLC/post-column derivatization for the determination of lanreotide, a human somatostatin analogue in urine.

79. Investigation of periodontitis, halitosis, xerostomia, and serological characteristics of patients with osteoarthritis and rheumatoid arthritis and identification of new biomarkers.

80. Enhanced Tumor Targeting and Antitumor Activity of Methylated β-Cyclodextrin-Threaded Polyrotaxanes by Conjugating Cyclic RGD Peptides.

81. In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation.

82. A comparison of the performance of 68 Ga-Pentixafor PET/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism.

85. Further structural optimization and SAR study of sungsanpin derivatives as cell-invasion inhibitors.

86. Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody-Positive At-Risk Individuals Without Arthritis.

87. Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling.

88. Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [ 18 F]FDG.

89. Emerging role of carbonyl-carbonyl interactions in the classification of beta turns.

90. An international simulated-use study to assess nurses' preferences between two lanreotide syringes for patients with neuroendocrine tumours or acromegaly (PRESTO 3).

92. Creating large chromosomal segment deletions in Aspergillus flavus by a dual CRISPR/Cas9 system: Deletion of gene clusters for production of aflatoxin, cyclopiazonic acid, and ustiloxin B.

94. Structure prediction of linear and cyclic peptides using CABS-flex.

95. Bioconversion of waste glycerol into viscosinamide by Pseudomonas fluorescens DR54 and its activity evaluation.

96. Total Synthesis of Cyanobactin Natural Product Balgacyclamide B.

97. IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis.

98. Oral administration of Bifidobacterium longum ES1 reduces endometrial inflammation in women with recurrent pregnancy loss.

99. Should ACR/EULAR criteria be revised changing the RF and ACPA scores?

100. Evaluating the use of preparation guides in interteaching versus a quiz alternative.

Catalog

Books, media, physical & digital resources